Drug Discovery Technology marketplace is rapidly affected because of the scientific and technological changes and advancements that are continuously going down round the world. This market contributes extremely within the growth of whole pharmaceutical business as they assist in introduction of recent medication. the world drug discovery market is projected to grow spectacular throughout the forecasted amount growing at a CAGR of 15% throughout 2022-2027. Adoption of worldwide drug discovery market is driven by following factors: like rising incidences of chronic diseases, rising demand for novel drug discovery technologies and advancement in field of biotechnology. There square measure several forces that drive the world drug discovery market, a number of that embody the increasing adoption of technology by the researchers within the development of recent medication. The marketplace for HTS (High output screening) holds the most important market share, thanks to the inflated use of the cell primarily based assays and AI within the parallel screening of the compounds. The increasing geriatric population needs a lot of attention facilities and therefore demands new medication to cope up with the varied health problems that occur because of aging. The emergence of recent diseases like viral hemorrhagic fever and H1N1 flu conjointly forces the pharmaceutical company corporations and analysis companies to figure towards development of newer molecules and target medication.
The factors the restrain the expansion of the world drug discovery market square measure the slow growth and development of recent medication could hamper the expansion of this market. Also, the expiration of patents of the main medication and also the Brobdingnagian value and time issue that’s concerned within the drug discovery hamper the expansion of the world drug discovery market. The market may be a extremely regulated; therefore face demanding rules and approval problems from government authorities. because of that corporations face the problem of delayed product launches because of long and costly approval method.
Market Insights
The global Drug Discovery Technologies market is expected to be around US$ 111 Billion by 2028, at a CAGR of 8.9% in the given forecast period.
The global Drug Discovery Technologies market is segregated on the basis of Technology as High Throughput Screening (HTS), Genomics, Biochips, Bioanalytical Instruments, Bioinformatics, Proteomics, Nanotechnology, and Other Technologies. Based on Application the global Drug Discovery Technologies market is segmented in Cancer, Cardiovascular Diseases, Central Nervous System Disorders, and Other Applications. Based on End User the global Drug Discovery Technologies market is segmented in Pharmaceutical Companies, Biopharmaceutical Companies, Biotech Companies, Research Institutes, and Other End User.
The global Drug Discovery Technologies market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Drug Discovery Technologies market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Albany Molecular Research Inc. (Amri), Arqule, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hoffmann-La Roche Ag, Evotec A.G., Charles River Laboratories, Inc., Celera Corporation, Abbott Laboratories, and others are among the major players in the global Drug Discovery Technologies market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drug Discovery Technologies Market has been segmented as below:
Drug Discovery Technologies Market, By Technology
Drug Discovery Technologies Market, By Application
Drug Discovery Technologies Market, By End User
Drug Discovery Technologies Market, By Region
Drug Discovery Technologies Market, By Company
The report covers:
Report Scope:
The global Drug Discovery Technologies market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Drug Discovery Technologies market share. Major industry players with significant revenue share include Albany Molecular Research Inc. (Amri), Arqule, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hoffmann-La Roche Ag, Evotec A.G., Charles River Laboratories, Inc., Celera Corporation, Abbott Laboratories, Application B10, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Drug Discovery Technologies Market, By Technology
5.1 Introduction
5.2 High Throughput Screening (HTS)
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Genomics
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Biochips
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Bioanalytical Instruments
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Bioinformatics
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Proteomics
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Nanotechnology
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Other Technologies
5.9.1 Market Overview
5.9.2 Market Size and Forecast
6. Drug Discovery Technologies Market, By Application
6.1 Introduction
6.2 Cancer
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Cardiovascular Diseases
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Central Nervous System Disorders
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Other Applications
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Drug Discovery Technologies Market, By End User
7.1 Introduction
7.2 Pharmaceutical Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Biopharmaceutical Companies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Biotech Companies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Research Institutes
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Other End User
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Drug Discovery Technologies Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Drug Discovery Technologies, By Technology
8.2.2 North America Drug Discovery Technologies, By Application
8.2.3 North America Drug Discovery Technologies, By End User
8.3 Europe
8.3.1 Europe Drug Discovery Technologies, By Technology
8.3.2 Europe Drug Discovery Technologies, By Application
8.3.3 Europe Drug Discovery Technologies, By End User
8.4 Asia-Pacific
8.4.1 Asia-Pacific Drug Discovery Technologies, By Technology
8.4.2 Asia-Pacific Drug Discovery Technologies, By Application
8.4.3 Asia-Pacific Drug Discovery Technologies, By End User
8.5 Rest of the World
8.5.1 Rest of the World Drug Discovery Technologies, By Technology
8.5.2 Rest of the World Drug Discovery Technologies, By Application
8.5.3 Rest of the World Drug Discovery Technologies, By End User
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Albany Molecular Research Inc. (Amri)
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Arqule, Inc.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Bio-Rad Laboratories, Inc.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Hoffmann-La Roche Ag
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Evotec A.G.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Charles River Laboratories, Inc.
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Celera Corporation
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
The Drug Discovery Technologies Market has been segmented as below:
Drug Discovery Technologies Market, By Technology
High Throughput Screening (HTS)
Drug Discovery Technologies Market, By Application
Drug Discovery Technologies Market, By End User
Drug Discovery Technologies Market, By Region
Drug Discovery Technologies Market, By Company
